TASS/. An intranasal anti-coronavirus vaccine, which is being developed by the St. Petersburg-based Research Institute of Influenza, demonstrated its efficiency and safety during pre-clinical ...

SK bioscience can maintain year-round vaccine production, improving supply stability and cost efficiency in the global market. SKYCellflu is the world's first cell culture-based influenza vaccine ...